Premium
Amount of mpl on bone marrow haemopoietic precursor cells from healthy volunteers and patients with refractory anaemia
Author(s) -
Takeshita Akihiro,
Shinjo Kaori,
Naito Kensuke,
Nakamura Satoki,
Izumi Masakazu,
Ling Pan,
Ohnishi Kazunori,
Ohno Ryuzo
Publication year - 1997
Publication title -
british journal of haematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.907
H-Index - 186
eISSN - 1365-2141
pISSN - 0007-1048
DOI - 10.1046/j.1365-2141.1997.4923296.x
Subject(s) - bone marrow , cd34 , cd38 , megakaryocyte , flow cytometry , haematopoiesis , immunology , microbiology and biotechnology , chemistry , myeloid , cancer research , biology , stem cell
Using a non‐isotopic ligand binding assay using multi‐colour flow cytometry, we quantitatively examined the amount of mpl in megakaryocyte‐platelet lineage cells. Firstly, we quantified the amount of mpl on cell lines. Mpl gene‐transfected BaF3 cells expressed a large amount of mpl , whereas original BaF3, K562, HL‐60 and NOMO‐1 cells showed no mpl . In bone marrow cells from healthy volunteers, mpl was expressed on CD34 + cells from the very early stage of differentiation when they had no CD38 antigen. The amount of mpl increased with differentiation to CD34 + CD41 + cells, but decreased with further differentiation to CD34 − CD41 + cells. In CD34 + CD41 + cells the amount of mpl varied according to cell size: abundant in large cells, moderate in medium‐size cells and a little in small cells. In bone marrow cells from patients with refractory anaemia (RA), the amount of mpl was decreased compared with that in bone marrow cells from healthy volunteers. When analysed by the same CD phenotype and same cell size, the amount of mpl was less in RA patients compared with that in healthy volunteers in all phenotypes and sizes tested. The proportion of large CD34 + CD41 + cells was less in RA patients than in normal volunteers.